Abstract
Purpose
To evaluate the effect of dexpanthenol 2%/sodium hyaluronate 0.15% eye drops on corneal epithelial healing and corneal microstructural changes following corneal cross-linking (CXL) in patients with keratoconus.
Methods
The study included 42 eyes of 21 patients with keratoconus who underwent CXL on both eyes. One eye of each patient was instilled dexpanthenol 2%/sodium hyaluronate 0.15% eye drops (DP/SH group) and the fellow eye was instilled unpreserved sodium hyaluronate 0.15% eye drops (SH group). The epithelial healing process was assessed every day until complete reepithelialization was achieved. The in vivo confocal microscopy (IVCM) findings were also recorded.
Results
The mean epithelial defect size 48.6 ± 6.7 mm2 for the DP/SH group and 48.2 ± 5.3 mm2 for the SH group. Complete reepithelialization was seen after 2.24 ± 0.44 days (range 2–4 days) in the DP/SH group and 3.43 ± 0.60 days (3 to 5 days) in the SH group. Posterior keratocyte density and endothelial cell density were similar in both groups. The mean subbasal nerve plexus density was significantly higher in the DP/SH group (postoperative 1 month: 1.13 ± 1.51, 3 months: 3.53 ± 2.55, 6 months: 7.07 ± 1.42) compared to the SH group (postoperative 1 month: 0.87 ± 1.43, 3 months: 2.89 ± 2.62, 6 months 6.33 ± 1.29). The DP/SH group revealed faster subbasal nerve regeneration and less edema compared to the SH group.
Conclusion
Dexpanthenol 2%/sodium hyaluronate 0.15% eye drops were effective and safe for corneal epithelial healing, and promoted faster corneal reepithelialization, nerve regeneration, and keratocyte repopulation with reduced corneal edema compared to sodium hyaluronate eye drops.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Data availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Feder RS, Kshettry P (2005) Noninflammatory ectatic disorders. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea. Elsevier-Mosby, Philadelphia, pp 955–974
Romero-Jiménez M, Santodomingo-Rubido J, Wolffsohn JS (2010) Keratoconus: a review. Contact Lens Anterior Eye 33:157–166. https://doi.org/10.1016/j.clae.2010.04.006
Mas Tur V, MacGregor C, Jayaswal R, O’Brart D, Maycock N (2017) A review of keratoconus: diagnosis, pathophysiology, and genetics. Surv Ophthalmol 62:770–783. https://doi.org/10.1016/j.survophthal.2017.06.009
Saad S, Saad R, Jouve L, Kallel S, Trinh L, Goemaere I, Borderie V, Bouheraoua N (2020) Corneal crosslinking in keratoconus management. J Fr Ophtalmol 43:1078–1095. https://doi.org/10.1016/j.jfo.2020.07.002
Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620–627. https://doi.org/10.1016/s0002-9394(02)02220-1
Seiler TG, Schmidinger G, Fischinger I, Koller T, Seiler T (2013) Komplikationen der Vernetzung der Hornhaut [complications of corneal cross-linking]. Ophthalmologe 110:639–644. https://doi.org/10.1007/s00347-012-2682-0
Ozek D, Kemer OE (2018) Effect of the bioprotectant agent trehalose on corneal epithelial healing after corneal cross-linking for keratoconus. Arq Bras Oftalmol 81:505–509. https://doi.org/10.5935/0004-2749.20180100
Ondes Yilmaz F, Kepez Yildiz B, Tunc U, Kandemir Besek N, Yildirim Y, Demirok A (2021) Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking: short term results. Ocul Immunol Inflamm 9:1–7. https://doi.org/10.1080/09273948.2020.1858117
Kymionis GD, Liakopoulos DA, Grentzelos MA, Tsoulnaras KI, Detorakis ET, Cochener B, Tsilimbaris MK (2015) Effect of the regenerative agent poly (carboxymethylglucose sulfate) on corneal wound healing after corneal cross-linking for keratoconus. Cornea 34:928–931. https://doi.org/10.1097/ico.0000000000000484
Bata AM, Witkowska KJ, Wozniak PA, Fondi K, Schmidinger G, Pircher N, Szegedi S, Aranha Dos Santos V, Pantalon A, Werkmeister RM, Garhofer G, Schmetterer L, Schmidl D (2016) Effect of a matrix therapy agent on corneal epithelial healing after standard collagen cross-linking in patients with keratoconus: a randomized clinical trial. JAMA Ophthalmol 134:1169–1176. https://doi.org/10.1001/jamaophthalmol.2016.3019
Baumeister M, Bühren J, Ohrloff C, Kohnen T (2009) Corneal re-epithelialization following phototherapeutic keratectomy for recurrent corneal erosion as in vivo model of epithelial wound healing. Ophthalmologica 223:414–418. https://doi.org/10.1159/000230880
Proksch E, de Bony R, Trapp S, Boudon S (2017) Topical use of dexpanthenol: a 70th anniversary article. J Dermatol Treat 28:766–773. https://doi.org/10.1080/09546634.2017.1325310
Brown SE, Simmasalam R, Antonova N, Gadaria N, Asbell PA (2014) Progression in keratoconus and the effect of corneal cross-linking on progression. Eye Contact Lens 40:331–338. https://doi.org/10.1097/icl.0000000000000085
Hersh PS, Greenstein SA, Fry KL (2011) Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg 37:149–160. https://doi.org/10.1016/j.jcrs.2010.07.030
Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, Thuret G (2016) Global survey of corneal transplantation and eye banking. JAMA Ophthalmol 134:167–173. https://doi.org/10.1001/jamaophthalmol.2015.4776
Kobashi H, Rong SS, Ciolino JB (2018) Transepithelial versus epithelium-off corneal crosslinking for corneal ectasia. J Cataract Refract Surg 44:1507–1516. https://doi.org/10.1016/j.jcrs.2018.08.021
Bikbova G, Bikbov M (2016) Standard corneal collagen crosslinking versus transepithelial iontophoresis-assisted corneal crosslinking, 24 months follow-up: randomized control trial. Acta Ophthalmol 94:e600–e606. https://doi.org/10.1111/aos.13032
Taneri S, Oehler S (2015) Komplikationen nach Hornhautquervernetzung [complications after corneal cross-linking]. Klin Monbl Augenheilkd 232:51–60. https://doi.org/10.1055/s-0034-1382963
Carlson E, Kao WWY, Ogundele A (2018) Impact of hyaluronic acid-containing artificial tear products on reepithelialization in an in vivo corneal wound model. J Ocul Pharmacol Ther 34:360–364. https://doi.org/10.1089/jop.2017.0080
Bonzano C, Cutolo CA, Musetti D, Di Mola I, Pizzorno C, Scotto R, Traverso CE (2021) Delayed re-epithelialization after epithelium-off crosslinking: predictors and ımpact on keratoconus progression. Front Med (Lausanne) 8:657993. https://doi.org/10.3389/fmed.2021.657993
Vinciguerra P, Albè E, Trazza S, Seiler T, Epstein D (2009) Intraoperative and postoperative effects of corneal collagen cross-linking on progressive keratoconus. Arch Ophthalmol 127:1258–1265. https://doi.org/10.1001/archophthalmol.2009.205
Hamdi IM (2018) Effect of D-Panthenol on corneal epithelial healing after surface laser ablation. J Ophthalmol 2018:6537413. https://doi.org/10.1155/2018/6537413
Mazzotta C, Caporossi T, Denaro R, Bovone C, Sparano C, Paradiso A, Baiocchi S, Caporossi A (2012) Morphological and functional correlations in riboflavin UV a corneal collagen cross-linking for keratoconus. Acta Ophthalmol 90:259–265. https://doi.org/10.1111/j.1755-3768.2010.01890.x
Zare MA, Mazloumi M, Farajipour H, Hoseini B, Fallah MR, Mahrjerdi HZ, Abtahi MA, Abtahi SH (2016) Effects of corneal collagen crosslinking on confocal microscopic findings and tear indices in patients with progressive keratoconus. Int J Prev Med 7:132. https://doi.org/10.4103/2008-7802.196527
Mazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C, Caporossi A (2007) Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by heidelberg retinal tomograph II in vivo confocal microscopy in humans. Cornea 26:390–397. https://doi.org/10.1097/ico.0b013e318030df5a
Mazzotta C, Traversi C, Baiocchi S, Caporossi O, Bovone C, Sparano MC, Balestrazzi A, Caporossi A (2008) Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications. Am J Ophthalmol 146:527–533. https://doi.org/10.1016/j.ajo.2008.05.042
Korkmaz MF, Parlakpinar H, Erdem MN, Ceylan MF, Ediz L, Samdanci E, Kekilli E (2020) The therapeutic efficacy of dexpanthenol on sciatic nerve injury in a rat model. Br J Neurosurg 34:397–401. https://doi.org/10.1080/02688697.2020.1749984
Cagini C, Messina M, Torroni G, Riccitelli F, Mariniello M, Dua HS (2020) Efficacy of topical microemulsion of fatty acids of the ω-3 series on the sub-epithelial corneal nerves regeneration after epithelium-off corneal collagen cross-linking for keratoconus. Int Ophthalmol 40:205–212. https://doi.org/10.1007/s10792-019-01170-0
Li-Mei W, Jie T, Shan-He W, Dong-Mei M, Peng-Jiu Y (2016) Anti-inflammatory and anti-oxidative effects of dexpanthenol on lipopolysaccharide induced acute lung injury in mice. Inflammation 39:1757–1763. https://doi.org/10.1007/s10753-016-0410-7
Çerman E, Özcan DÖ, Toker E (2017) Sterile corneal infiltrates after corneal collagen cross-linking: evaluation of risk factors. Acta Ophthalmol 95:199–204. https://doi.org/10.1111/aos.13218
Funding
The authors obtained no commercial provider for the investigation, authorship, and broadcasting of the study.
Author information
Authors and Affiliations
Contributions
HS, MA: designed the study; HS, MA: were involved in patient care; HS, MA: collected the data; HS, MA: analysis and interpretation of data; HS: drafting the manuscript; HS, MA: design of the work, revising the work critically for important intellectual content. All authors approved the final version of manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no financial conflict of interest related to this article.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey and with the 1964 Helsinki declaration and its later amendments or comparable wit ethical standards. Written informed consent was obtained from all individual participants included in the study.
Consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey and with the 1964 Helsinki declaration and its later amendments or comparable wit ethical standards. Written informed consent was obtained from all individual participants included in the study.
Consent for publication
The authors declare they have participated in this work, and they have reviewed the final version of the work, believe it represents valid work, and approve it for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sabur, H., Acar, M. Dexpanthenol/sodium hyaluronate eye drops for corneal epithelial healing following corneal cross-linking in patients with keratoconus. Int Ophthalmol 43, 3461–3469 (2023). https://doi.org/10.1007/s10792-023-02751-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-023-02751-w